<DOC>
	<DOCNO>NCT01772524</DOCNO>
	<brief_summary>The purpose study assess safety , pharmacokinetics efficacy single dose ALD403 prevention migraine headache frequent episodic migraineurs 24 week .</brief_summary>
	<brief_title>Safety , Efficacy Pharmacokinetics ALD403</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Inclusion Criteria Diagnosis migraine ≤ 50 year age ( ICHDII , 2004 Section 1 ) History migraine ≥ 12 month ≥ 5 ≤ 14 migraine day 28 day period 3 month prior screen use acute migraine medication ≤ 14 day per 28 day period , within day , ≤ 10 day triptan use per 28 day period 3 month prior screen 28 day period completion eDiary prior randomization Women childbearing potential male partner childbearing potential must agree use adequate contraception ( oral injectable [ depot ] estrogen , and/or progestogen , selective estrogen receptor modulator contraceptive therapeutic , intrauterine contraceptive device , double barrier method [ e.g. , condom diaphragm spermicidal gel ] ) . Nonchildbearing potential define postmenopausal least 1 year surgical sterilization hysterectomy least 3 month screen Any hormonal therapy ( e.g. , oral contraceptive , hormone replacement therapy ) use stable ongoing least 3 month prior screen 28 day period screen randomization Agree post personal medical data relate trial information relate trial website social medium site ( e.g. , Facebook , Twitter ) trial complete Exclusion Criteria Confounding pain syndrome include fibromyalgia , chronic musculoskeletal ( e.g. , low back pain ) , psychiatric condition , dementia , major neurological disorder migraine interfere participation trial Diagnosis complicate migraine , chronic tensiontype headache , hypnic headache , hemicrania continuum , new daily persistent headache , basilar , hemiplegic , familial hemiplegic migraine Regular use ( great 7 day ) prophylactic headache medication ( preventive medication supplement evidence efficacy least 1 placebocontrolled trial ) within 3 month , onabotulinumtoxin A within 6 month prior screen 28 day period prior randomization Cardiac surgery cardiac symptom within 3 month screen 28 day period prior randomization Suspected diagnosis hypertension without antihypertensive treatment Any ongoing comorbidity opinion Investigator interfere participation trial Body Mass Index ( BMI ) &gt; 39 screening Pregnant , breastfeeding , plan become pregnant trial Patients used opioids &gt; 5 day treatment pain 2 6 month prior screen 28 day period prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Migraine Disorders</keyword>
	<keyword>Phase 1</keyword>
	<keyword>ALD403</keyword>
</DOC>